ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells

Immunology

Volumn 94, Issue 4, 1998, Pages 496-502

  Labuda, T ^a   Wendt, J ^a   Hedlund, G ^a,b   Dohlsten, M ^a  

^a LUND UNIVERSITY   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2; SUPERANTIGEN;

ARTICLE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

BIOLOGICAL MARKERS; CELL LINE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; SUPERANTIGENS;

EID: 0031877434     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00540.x     Document Type: Article

References (50)

1. MUELLER D.L., JENKIZS M.K. & SCHWARTZ R.H. (1989) Clonal expansion versus functional clonal inactivation a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Ann Rev Immunol 7, 445.
2. ALTMAN A., COGGESHALL K.M. & MUSTELIN T. (1990) Molecular events mediating T cell activation. Adv Immunol 48, 227.
3. VAN SEVENTER G.A., SIIIMIZU Y. & SHAW S. (1991) Roles of multiple accessory molecules in T-cell activation. Curr Opin Immunol 3, 294.
4. SPRINGER T.A. (1990) Adhesion receptors of the immune system. Nature Lond 346, 425.
5. VAN SEVENTER G.A., SIHMIZU Y., HOROAN K.J. & SIIAW S. (1990) The LFA-1 ligand ICAM-I provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 144, 4579.
6. FISCHER H., GJORLOFF A., HEDLUND G. et al. (1992) Stimulation of human naive and memory T helper cells with bacterial superantigen naive CD4-positivc 45RA-positive T cells require a costimulatory signal mediated through the LFA-1-ICAM-1 pathway. J Immunol 148, 1993.
7. WINGREN A.C., DAHLENBORG K., BJORKLUND M. et al (1993) Monocyte-regulated IFN-γ production in human T cells involves CD2 signaling. J Immunol 151, 1328.
8. JENKINS M.K. & SCHWARTZ R.H. (1987) Antigen presentation of chemically modified splenocytes induces antigen-specific T cell unresponsiveness in-vitro and in-vivo. J Exp Med 165, 302.
9. BOUSSIOTIS V.A., GRIBBEN J.G., FREEMAN G.J. & NADLER L.M. (1994) Blockade of the CD28 co-stimulatory pathway: A means to induce tolerance. Curr Opin Immunol 6, 797.
10. PARRA E., WINGREN A.G., HEDLUND G. et al. (1994) Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles. J Immunol 153, 2479.
11. + T cells. J Exp Med 173, 759.
12. AZUMA M., CAYABYAB M., PHILLIPS J.H. & LANIER L.L. (1993) Requirements for CD28-depcndent T cell-mediated cytotoxicity. J Immunol 150, 2091.
13. DUBEY C, CROFT M. & SWAIN S.L. (1995) Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7 can costimulate naive CD4T cell activation but both are required for optimum response. J Immunol 155, 45.
14. CAVALLO F., MARTIN-FONTECHA A., BELLONE M. et al. (1995) Co-expression of B7 and ICAM-I on tumors is required for rejection and the establishment of a memory response. Eur J Immunol 25, 1154.
15. DAMLE N.K., KLUSSMAN K., LEYTZE G. & LINSLEY P.S. (1993) Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7. J Immunol 150, 726.
16. DE FOUGEROLLES A.R., STACKER S.A., SCHWARTING R. & SPRINGER T.A. (1991) Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 174, 253.
17. FAWCETT J., HOLNESS C.L.L., NEEDHAM L.A. et al (1992) Molecular cloning of ICAM-3 a third ligand for LFA-1 constitutively expressed on resting leukocytes. Nature Lond 360, 481.
18. ALTMANN D.M., HOGG N., TROWSDALE J. & WILINSON D. (1989) Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen- presenting cell function in mouse L cells. Nature Lond 338, 512.
19. STARLING G.C., McLELAN A.D., EGNER W. et al (1995) Intercellular adhesion molecule-3 is the predominant co-stimulatory ligand for leukocyte function antigen-1 on human blood dendritic cells. Eur J Immunol 25, 2528.
20. FIORENTINO D.F., BOND M.W. & MOSMANN T.R. (1989) Two types of mouse T helper cell Iv. Th2 clones secrete a factor that inhibits cylokine production by Th1 clones. J Exp Med 170, 2081.
21. VIEIRA P., DE WAAL-MALEEYT R., DANG M.N. et al (1991) Isolation and expression of human cytokine synthesis inhibitory factor complementary DNA clones homology to Epstein Barr virus open reading frame bcrfi. Proc Natl Acad Sci USA 88, 1172.
22. KENNEDY M.K., PICHA K.S., SHANEBECK K.D., ANDERSON D.M. & GRABSTEIN K.H. (1994) Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur J Immunol 24, 2271.
23. FIORENTINO D.F., ZLOTNTK A., VIEIRA P. et al. (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146, 3444.
24. SUNDSTEDT A., HOIDEN I., HANSSON J., HEDLUND G., KALLAND T. & DOHLSTEN M. (1995) Superantigen-induced anergy in cytotoxic CD8+ T cells. J Immunol 154, 6306.
25. BOYD A.W., WAWRYK S.O., BURNS G.F. & FECONDO J.V. (1988) Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci USA 85, 3095.
26. ABRAHMSKN L., DOHLSTEN M., SEGRHN S., BJORK P., JONSSON E. & KALLAND T. (1995) Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 14, 2978.
27. WILKINSON D., DE VRIES R.R., MADRIGAL J.A. et al. (1988) Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients. J Exp Med 167, 1442.
28. CARLSSON R., FISCHER H. & SJOGREN H.O. (1988) Binding of staphylococcal enterotoxin a to accessory cells is a requirement for its ability to activate human T cells. J Immunol 140, 2484.
29. DOHLSTEN M., SJOGREN H.O. & CARLSSON R. (1986) Histamine inhibits interferon-gamma production via suppression of interleukin 2 synthesis. Cell Immunol 101, 493.
30. FISCHER H., DOHLSTEN M., ANDERSSON U. et al. (1990) Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T cell. J Immunol 144, 4663.
31. CARLSSON R. & SJOGREN H.O. (1985) kinetics of interleukin-2 and interferon-γ production expression of interleukin-2 receptors and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell Immunol 96, 175.
32. LANDO P.A., OLSSON C., KALLAND T., NEWTON D., KOTB M. & DOHLSTEN M. (1996) Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. J Immunol 157, 2857.
33. DAMLE: N.K., KLUSSMAN K., LINSLEY P.S., ARUFEO A. & LEDBETTER J.A. (1992) Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J Immunol 149, 2541.
34. DE WAAL M.R., ABRMS J., BENNETT B., FIGDOR C.G. & E.D.V.-J. (1991) Interleukin 10, IL10 inhibits cytokine synthesis by human monocytes an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174, 1209.
35. DE WAAL-MALEFYT R., DE YSSEL H. & V.-J.E. (1993) Direct effects of IL-10 on subsets of human CD4 positive T cell clones and resting T cells specific inhibition of IL-2 production and proliferation. J Immunol 150, 4754.
36. BUELENS C., WILLEMS F., DELVAUX A. et al. (1995) Interleukin-10 differentially regulates B7 (CD80) and B7 (CD86): expression on human peripheral blood dendritic cells. Eur J Immunol 25, 2668.
37. KUHN R., LOHLER J., RENNICK D., RAJEWSKY K. & MULLER W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis [see comments]. Cell 75, 263.
38. MARCHANT A., BRUYNS C., VANDENABEELE P. et al. (1994) Interleukin-10 controls intcrferon-y and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24, 1167.
39. MARCELLETTI J.F., OHARA J. & KATZ D.H. (1991) Collageninduced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease. J Immunol 147, 4185.
40. SAOUDI A., KUHN J., HUYGEN K. et al. (1993) TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 23, 3096.
41. KENNEDY M.K., TORRANCE D.S., PICHA K.S. & MOHLER K.M. (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149, 2496.
42. + Tcell subset that inhibits this autoimmune potential. J Exp Med 177, 627.
43. KHOURY S.J., HANCOCK W.W. & WEINER H.L. (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176, 1355.
44. YOKOTA A., MURAIA N., SAIKI O., SHIMIZU M., SPRINGER T.A. & KISHIMOTO T. (1995) High avidity state of leukocyte functionassociated antigen-1 on rheumatoid synovial fluid T lymphocytes. J Immunol 155, 4118.
45. Wu M.X., Ao Z., HEGEM M., MORIMOTO C. & SCHLOSSMAN S.F. (1996) Requirement of Fas (CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells. J Immunol 157, 707.
46. DAVIS L.S., KAVANAUGH A.F., NICHOLS L.A. & LIPSKY P.E. (1995) Induction of persistent T cell hyporcsponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J Immunol 154, 3525.
47. KAVANAUGH A.F., DAVIS L.S., JAIN R.I., NICHOLS L.A., NORRIS S.H. & LIPSKY P.E. (1996) A phase I/II open label study of the safety and efficacy of an anti- ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis [in process citation]. J Rheumatol 23, 1338.
48. SSHULZE-KOOPS H., LIPSKY P.E., KAVANAUGH A.F. & DAVIS L.S. (1995) Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti- ICAM-1 correlates with clinical benefit. J Immunol 155, 5029.
49. HALLAHAN D.E. & VIRUDACHALAM S. (1997) Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. Proc Natl Acad Sci USA 94, 6432.
50. BULLARD D.C., HURLEY L.A., LORENZO I., SLY L.M., BEAUDET A.L. & STAITE-: N.D. (1996) Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule-1. J Immunol 157, 3153.